News

A new biomarker, uncovered by researchers in the University of Kentucky College of Pharmacy, could change cardiovascular care for patients with high risk of disease.

Ten years ago, UK administrators, students, faculty and staff made the decision to become a tobacco-free campus. Since then, the university has become a healthier place to live, work and learn.

UK Professor of Pharmacology and Nutritional Sciences Nancy Webb, Ph.D., has been honored by the American Heart Association with the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Distinguished Achievement Award.

Dr. Jennifer Smith's work highlights a specific gene that makes certain compounds taste bitter, making it more difficult for some people at risk of cardiovascular disease (CVD) to add heart-healthy veggies to their diet.

Researchers from the UK College of Nursing are asking health care providers to consider the potential effects of e-cigarettes when advising patients on what they can do to prevent heart disease.

New research at UK has confirmed that the presence of XX sex chromosomes increases the amount of fat circulating in the blood, which leads to narrowing of the arteries and ultimately a higher risk of heart attacks and coronary artery disease.

The University of Kentucky is a place defined by its people. This Wednesday, April 17, our community will band together during our first “One Day for UK,” a 24-hour day of giving. As part of the campaign, UK Research is raising money for the Healthy Kentucky Research Building Fund.

Last week, more than 200 faculty, staff, and trainees from across the nation attended the Gill Heart & Vascular Institute's Cardiovascular Research Day to share the latest research on cardiovascular health.

A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.